Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

CD21-/low B cells associate with joint damage in rheumatoid arthritis patients.

Thorarinsdottir K, Camponeschi A, Jonsson C, Granhagen Önnheim K, Nilsson J, Forslind K, Visentini M, Jacobsson L, Mårtensson IL, Gjertsson I.

Scand J Immunol. 2019 May 29:e12792. doi: 10.1111/sji.12792. [Epub ahead of print]

PMID:
31141193
2.

Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort.

Hafström I, Ajeganova S, Forslind K, Svensson B.

Arthritis Res Ther. 2019 Feb 4;21(1):45. doi: 10.1186/s13075-019-1833-y.

3.

Repair of Erosions in Patients with Rheumatoid Arthritis.

Forslind K, Eberhardt K, Svensson B.

J Rheumatol. 2019 Feb 1. pii: jrheum.180557. doi: 10.3899/jrheum.180557. [Epub ahead of print]

PMID:
30709948
4.

Importance of Measuring Hand and Foot Function Over the Disease Course in Rheumatoid Arthritis: An Eight-Year Follow-Up Study.

Bremander A, Forslind K, Eberhardt K, Andersson MLE.

Arthritis Care Res (Hoboken). 2019 Feb;71(2):166-172. doi: 10.1002/acr.23764.

PMID:
30251481
5.

Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis.

Rydell E, Forslind K, Nilsson JÅ, Jacobsson LTH, Turesson C.

Arthritis Res Ther. 2018 May 2;20(1):82. doi: 10.1186/s13075-018-1575-2.

6.

Measuring person-centred care in nurse-led outpatient rheumatology clinics.

Bala SV, Forslind K, Fridlund B, Hagell P.

Musculoskeletal Care. 2018 Jun;16(2):296-304. doi: 10.1002/msc.1234. Epub 2018 Feb 27.

PMID:
29484828
7.

Person-centred care in nurse-led outpatient rheumatology clinics: Conceptualization and initial development of a measurement instrument.

Bala SV, Forslind K, Fridlund B, Samuelson K, Svensson B, Hagell P.

Musculoskeletal Care. 2018 Jun;16(2):287-295. doi: 10.1002/msc.1233. Epub 2018 Feb 8.

PMID:
29417713
8.
9.

Fully automated joint space width measurement and digital X-ray radiogrammetry in early RA.

Platten M, Kisten Y, Kälvesten J, Arnaud L, Forslind K, van Vollenhoven R.

RMD Open. 2017 Jun 29;3(1):e000369. doi: 10.1136/rmdopen-2016-000369. eCollection 2017.

10.

Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year.

Ziegelasch M, Forslind K, Skogh T, Riklund K, Kastbom A, Berglin E.

Arthritis Res Ther. 2017 Sep 2;19(1):195. doi: 10.1186/s13075-017-1403-0.

11.

Patients with Early Rheumatoid Arthritis in the 2000s Have Equal Disability and Pain Despite Less Disease Activity Compared with the 1990s: Data from the BARFOT Study over 8 Years.

Andersson MLE, Forslind K, Hafström I; BARFOT Study Group.

J Rheumatol. 2017 Jun;44(6):723-731. doi: 10.3899/jrheum.161235. Epub 2017 Apr 1.

PMID:
28365578
12.

Living with persistent rheumatoid arthritis: a BARFOT study.

Bala SV, Samuelson K, Hagell P, Fridlund B, Forslind K, Svensson B, Thomé B.

J Clin Nurs. 2017 Sep;26(17-18):2646-2656. doi: 10.1111/jocn.13691. Epub 2017 Feb 9.

PMID:
28000296
13.

A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.

Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Wallman JK, Ernestam S, Bolce RJ, van Vollenhoven RF.

Arthritis Rheumatol. 2017 May;69(5):953-963. doi: 10.1002/art.40019. Epub 2017 Mar 31.

14.

Persistently active disease is common in patients with rheumatoid arthritis, particularly in women: a long-term inception cohort study.

Svensson B, Andersson M, Forslind K, Ajeganova S, Hafström I; BARFOT study group.

Scand J Rheumatol. 2016 Nov;45(6):448-455. Epub 2016 Apr 20.

PMID:
27095008
15.

The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.

Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafström I, Toes RE, Huizinga TW, Svensson B, Trouw LA, van der Helm-van Mil AH.

Ann Rheum Dis. 2017 Jan;76(1):112-118. doi: 10.1136/annrheumdis-2015-208870. Epub 2016 Apr 26.

PMID:
27117699
16.

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.

Hambardzumyan K, Bolce RJ, Saevarsdottir S, Forslind K, Wallman JK, Cruickshank SE, Sasso EH, Chernoff D, van Vollenhoven RF.

RMD Open. 2016 Mar 1;2(1):e000197. doi: 10.1136/rmdopen-2015-000197. eCollection 2016.

17.

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.

Chatzidionysiou K, Turesson C, Teleman A, Knight A, Lindqvist E, Larsson P, Cöster L, Forslind K, van Vollenhoven R, Heimbürger M.

RMD Open. 2016 Jan 14;2(1):e000133. doi: 10.1136/rmdopen-2015-000133. eCollection 2016.

18.

MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.

Forslind K, Svensson B.

Scand J Rheumatol. 2016;45(2):99-102. doi: 10.3109/03009742.2015.1070902. Epub 2015 Aug 31.

PMID:
26313244
19.

Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.

van Vollenhoven RF, Bolce R, Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Sasso EH, Hwang CC, Segurado OG, Geborek P.

Arthritis Rheumatol. 2015 Nov;67(11):2855-60. doi: 10.1002/art.39274.

20.

Genetic Factors for the Severity of ACPA-negative Rheumatoid Arthritis in 2 Cohorts of Early Disease: A Genome-wide Study.

de Rooy DP, Tsonaka R, Andersson ML, Forslind K, Zhernakova A, Frank-Bertoncelj M, de Kovel CG, Koeleman BP, van der Heijde DM, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, Ospelt C, Svensson B, van der Helm-van Mil AH.

J Rheumatol. 2015 Aug;42(8):1383-91. doi: 10.3899/jrheum.140741. Epub 2015 Jun 15.

PMID:
26077402
21.

Predicted vs. observed radiographic progression in early rheumatoid arthritis (POPeRA): results from a randomized trial.

Levitsky A, Forslind K, van Vollenhoven RF; SWEFOT trial group.

Scand J Rheumatol. 2015;44(5):348-53. doi: 10.3109/03009742.2015.1019560. Epub 2015 May 20.

PMID:
25992914
22.

Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis - A BARFOT Study.

Andersson ML, Forslind K, Hafström I.

Open Rheumatol J. 2015 Feb 3;9:8-15. doi: 10.2174/1874312901409010008. eCollection 2015.

23.

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

Kastbom A, Forslind K, Ernestam S, Geborek P, Karlsson JA, Petersson IF, Saevarsdottir S, Klareskog L, van Vollenhoven RF, Lundberg K.

Ann Rheum Dis. 2016 Feb;75(2):356-61. doi: 10.1136/annrheumdis-2014-205698. Epub 2014 Dec 30.

24.

The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis.

van Steenbergen HW, Ajeganova S, Forslind K, Svensson B, van der Helm-van Mil AH.

Ann Rheum Dis. 2015 Jan;74(1):e3. doi: 10.1136/annrheumdis-2014-206623. Epub 2014 Oct 6. No abstract available.

PMID:
25288634
25.

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.

Hambardzumyan K, Bolce R, Saevarsdottir S, Cruickshank SE, Sasso EH, Chernoff D, Forslind K, Petersson IF, Geborek P, van Vollenhoven RF.

Ann Rheum Dis. 2015 Jun;74(6):1102-9. doi: 10.1136/annrheumdis-2013-204986. Epub 2014 May 8.

26.

Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial.

Saevarsdottir S, Rezaei H, Geborek P, Petersson I, Ernestam S, Albertsson K, Forslind K, van Vollenhoven RF; SWEFOT study group.

Ann Rheum Dis. 2015 Aug;74(8):1509-14. doi: 10.1136/annrheumdis-2013-204601. Epub 2014 Apr 4.

27.
28.

Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts.

de Rooy DP, van Nies JA, Kapetanovic MC, Kristjansdottir H, Andersson ML, Forslind K, van der Heijde DM, Gregersen PK, Lindqvist E, Huizinga TW, Gröndal G, Svensson B, van der Helm-van Mil AH.

Ann Rheum Dis. 2014 Jul;73(7):1384-7. doi: 10.1136/annrheumdis-2013-203940. Epub 2014 Jan 3.

PMID:
24389296
29.

Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria.

Svensson B, Andersson ML, Bala SV, Forslind K, Hafström I; BARFOT study group.

BMJ Open. 2013 Sep 10;3(9):e003554. doi: 10.1136/bmjopen-2013-003554.

30.

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.

Andersson ML, Svensson B, Petersson IF, Hafström I, Albertsson K, Forslind K, Heinegård D, Saxne T.

BMC Musculoskelet Disord. 2013 Aug 2;14:229. doi: 10.1186/1471-2474-14-229.

31.

EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis.

Colebatch AN, Edwards CJ, Østergaard M, van der Heijde D, Balint PV, D'Agostino MA, Forslind K, Grassi W, Haavardsholm EA, Haugeberg G, Jurik AG, Landewé RB, Naredo E, O'Connor PJ, Ostendorf B, Potocki K, Schmidt WA, Smolen JS, Sokolovic S, Watt I, Conaghan PG.

Ann Rheum Dis. 2013 Jun;72(6):804-14. doi: 10.1136/annrheumdis-2012-203158. Epub 2013 Mar 21.

32.

Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial.

Rezaei H, Saevarsdottir S, Geborek P, Petersson IF, van Vollenhoven RF, Forslind K.

BMC Musculoskelet Disord. 2013 Mar 5;14:79. doi: 10.1186/1471-2474-14-79.

33.

Ankylosis of wrist and small joints of the hand occurs in rheumatoid arthritis: Diagnostic implication in paleopathology.

Leden I, Forslind K, Svensson B; BARFOT study group.

Int J Paleopathol. 2012 Dec;2(4):249-251. doi: 10.1016/j.ijpp.2012.09.001. Epub 2012 Oct 31.

PMID:
29539374
34.

Does digital X-ray radiogrammetry have a role in identifying patients at increased risk for joint destruction in early rheumatoid arthritis?

Forslind K, Kälvesten J, Hafström I, Svensson B; BARFOT Study Group.

Arthritis Res Ther. 2012 Oct 15;14(5):R219. doi: 10.1186/ar4058.

35.

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial.

van Vollenhoven RF, Geborek P, Forslind K, Albertsson K, Ernestam S, Petersson IF, Chatzidionysiou K, Bratt J; Swefot study group.

Lancet. 2012 May 5;379(9827):1712-20. doi: 10.1016/S0140-6736(12)60027-0. Epub 2012 Mar 29.

PMID:
22464340
36.

Metastasin S100A4 is increased in proportion to radiographic damage in patients with RA.

Erlandsson MC, Forslind K, Andersson SE, Lund A, Bokarewa MI.

Rheumatology (Oxford). 2012 May;51(5):932-40. doi: 10.1093/rheumatology/ker362. Epub 2012 Jan 17.

PMID:
22258387
37.

The usefulness of the Simplified Erosion Narrowing Score (SENS) in clinical practice for estimating joint damage in early rheumatoid arthritis.

Forslind K; BARFOT Study Group.

Scand J Rheumatol. 2011 Nov;40(6):497-8. doi: 10.3109/03009742.2011.617313. No abstract available.

PMID:
22150250
38.

High survivin levels predict poor clinical response to infliximab treatment in patients with rheumatoid arthritis.

Isgren A, Forslind K, Erlandsson M, Axelsson C, Andersson S, Lund A, Bokarewa M.

Semin Arthritis Rheum. 2012 Apr;41(5):652-7. doi: 10.1016/j.semarthrit.2011.08.005. Epub 2011 Oct 28.

PMID:
22035627
39.

In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.

Rezaei H, Saevarsdottir S, Forslind K, Albertsson K, Wallin H, Bratt J, Ernestam S, Geborek P, Pettersson IF, van Vollenhoven RF.

Ann Rheum Dis. 2012 Feb;71(2):186-91. doi: 10.1136/annrheumdis-2011-200038. Epub 2011 Sep 19.

PMID:
21930734
40.

Long-term in-vitro precision of direct digital X-ray radiogrammetry.

Dhainaut A, Hoff M, Kälvesten J, Lydersen S, Forslind K, Haugeberg G.

Skeletal Radiol. 2011 Dec;40(12):1575-9. doi: 10.1007/s00256-011-1187-2. Epub 2011 May 11.

41.

The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.

Nyhäll-Wåhlin BM, Turesson C, Jacobsson LT, Nilsson JÅ, Forslind K, Albertsson K, Rönnelid J, Petersson IF.

Scand J Rheumatol. 2011 Mar;40(2):81-7. doi: 10.3109/03009742.2010.509103. Epub 2010 Oct 5.

PMID:
20919947
42.

Joint destruction in early rheumatoid arthritis over 8 years is similar in women and men despite apparently higher disease activity and poorer function in women.

Hafström I, Bala V, Albertsson K, Forslind K, Svensson B; BARFOT study group.

Ann Rheum Dis. 2011 Apr;70(4):709-10. doi: 10.1136/ard.2010.135343. Epub 2010 Aug 10. No abstract available.

PMID:
20699238
43.

Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis.

Svensson B, Hafström I, Forslind K, Albertsson K, Tarkowski A, Bokarewa M.

Ann Med. 2010;42(1):45-54. doi: 10.3109/07853890903376280.

PMID:
20092399
44.

Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis.

Forslind K, Boonen A, Albertsson K, Hafström I, Svensson B; Barfot Study Group.

Scand J Rheumatol. 2009 Nov-Dec;38(6):431-8. doi: 10.3109/03009740902939376.

PMID:
19922017
45.

Self-reported outcomes during treatment with tumour necrosis factor alpha inhibitors in patients with rheumatoid arthritis.

Bala SV, Forslind K, Månsson ME.

Musculoskeletal Care. 2010 Mar;8(1):27-35. doi: 10.1002/msc.163.

PMID:
19899068
46.

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.

van Vollenhoven RF, Ernestam S, Geborek P, Petersson IF, Cöster L, Waltbrand E, Zickert A, Theander J, Thörner A, Hellström H, Teleman A, Dackhammar C, Akre F, Forslind K, Ljung L, Oding R, Chatzidionysiou A, Wörnert M, Bratt J.

Lancet. 2009 Aug 8;374(9688):459-66. doi: 10.1016/S0140-6736(09)60944-2.

PMID:
19665644
47.

Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage.

Ahlmén M, Svensson B, Albertsson K, Forslind K, Hafström I; BARFOT Study Group.

Ann Rheum Dis. 2010 Jan;69(1):230-3. doi: 10.1136/ard.2008.102244.

PMID:
19158113
48.

Short-time in vitro and in vivo precision of direct digital X-ray radiogrammetry.

Hoff M, Dhainaut A, Kvien TK, Forslind K, Kälvesten J, Haugeberg G.

J Clin Densitom. 2009 Jan-Mar;12(1):17-21. doi: 10.1016/j.jocd.2008.10.005. Epub 2008 Dec 12.

PMID:
19070523
49.

Sex: a major predictor of remission in early rheumatoid arthritis?

Forslind K, Hafström I, Ahlmén M, Svensson B; BARFOT Study Group.

Ann Rheum Dis. 2007 Jan;66(1):46-52. Epub 2006 Dec 7.

50.

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B; BARFOT Study Group.

Ann Rheum Dis. 2004 Sep;63(9):1090-5.

Supplemental Content

Loading ...
Support Center